ArticleESMO gastrointestinal oncology2023

Assessment of the impact of FcγRIIIA single-nucleotide polymorphisms on the efficacy of IgG1 monoclonal antibodies in patients with advanced gastroesophageal adenocarcinoma.

A V Serritella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.